logo
Plus   Neg
Share
Email

American Express Reaffirms FY19 Outlook - Quick Facts

While reporting financial results for the second quarter, American Express Co. (AXP) on Friday reaffirmed its earnings and revenue growth guidance for the full-year 2019.

For fiscal 2019, the company continues to project earnings in the range of $7.64 to $8.14 per share and adjusted earnings in the range of $7.85 to $8.35 per share. The company's 2019 revenue growth guidance also remains 8 to 10 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $8.13 per share on revenue growth of 8.0 percent to $43.57 billion for the year. Analysts' estimates typically exclude special items.

Further, the company also plans to continue returning a significant portion of the capital it generates to shareholders and expects to increase the regular quarterly dividend on its common shares outstanding to 43 cents per share from 39 cents beginning with the third quarter 2019, subject to approval by the company's board of directors.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>